Phillip Hay
Overview
Explore the profile of Phillip Hay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donders G, Sziller I, Paavonen J, Hay P, De Seta F, Bohbot J, et al.
Front Cell Infect Microbiol
. 2022 Sep;
12:934353.
PMID: 36159646
Recurrent vulvovaginal candidosis (RVVC) is a chronic, difficult to treat vaginal infection, caused by species, which affects women of all ages and ethnic and social background. A long-term prophylactic maintenance...
2.
Kerry-Barnard S, Beddows S, Reid F, Beckley-Hoelscher N, Soldan K, Panwar K, et al.
Sex Transm Infect
. 2020 Sep;
97(6):458-460.
PMID: 32883750
Objectives: Oropharyngeal squamous cell carcinoma is the most common human papillomavirus (HPV)-associated cancer in the UK, but little is known about the prevalence of oropharyngeal HPV in sexually active teenagers....
3.
Hay P
F1000Res
. 2017 Oct;
6:1761.
PMID: 29043070
Bacterial vaginosis is the most prevalent cause of abnormal vaginal discharge in women of childbearing age. It can have a major impact on quality of life and psychological wellbeing if...
4.
Harding-Esch E, Nori A, Hegazi A, Pond M, Okolo O, Nardone A, et al.
Sex Transm Infect
. 2017 Feb;
93(6):424-429.
PMID: 28159916
Objectives: To assess clinical service value of STI point-of-care test (POCT) use in a 'sample first' clinical pathway (patients providing samples on arrival at clinic, before clinician consultation). Specific outcomes...
5.
Winston A, Jose S, Fisher M, Walsh J, Nelson M, Gilson R, et al.
J Allergy Clin Immunol
. 2015 Aug;
136(6):1682-1685.e1.
PMID: 26253341
No abstract available.
6.
Kerry S, Nightingale C, Hay P, Oakeshott P
Int J STD AIDS
. 2015 May;
27(7):586-90.
PMID: 25999170
Using data from the Prevention of Pelvic Infection (POPI) chlamydia screening trial, we compared the characteristics of female students who did or did not get tested for chlamydia outside the...
7.
Pond M, Nori A, Patel S, Laing K, Ajayi M, Copas A, et al.
Sex Transm Infect
. 2015 Jan;
91(3):165-70.
PMID: 25614466
Objectives: Gram-stained urethral smear (GSUS), the standard point-of-care test for non-gonococcal urethritis (NGU) is operator dependent and poorly specific. The performance of rapid automated urine flow cytometry (AUFC) of first...
8.
de Ruiter A, Taylor G, Clayden P, Dhar J, Gandhi K, Gilleece Y, et al.
HIV Med
. 2015 Jan;
15 Suppl 4:1-77.
PMID: 25604045
No abstract available.
9.
Jose S, Hamzah L, Campbell L, Hill T, Fisher M, Leen C, et al.
J Infect Dis
. 2014 Mar;
210(3):363-73.
PMID: 24585896
Background: Tenofovir disoproxil fumarate (TDF) has been linked to renal impairment, but the extent to which this impairment is reversible is unclear. We aimed to investigate the reversibility of renal...
10.
Jose S, Quinn K, Hill T, Leen C, Walsh J, Hay P, et al.
AIDS
. 2014 Mar;
28(9):1333-9.
PMID: 24583670
Objective: Few data describe antiretroviral treatment (ART)-related adverse events when treatment is initiated at CD4(+) cell counts more than 350 cells/μl. We compared rates of laboratory-defined adverse events (LDAEs) according...